Kv7.2 modulator therapy (Angelini Pharma)

N/A

Report date: 2025/05/28 11:27:23
NME

Base Information

Drug NameKv7.2 modulator therapy (Angelini Pharma)
Drug Alias NameSmall molecule Kv7.2 program
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 modulators
TargetsVoltage-gated potassium channel subunit Kv7.2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmniAb Inc
China Registration ClassN/A

Develop Information

Active CompaniesAngelini PharmaOmniAb Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A